Return On Assets of Unicycive Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Unicycive Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Unicycive Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -95%, a 55% decline year-over-year.
  • Unicycive Therapeutics, Inc. annual Return On Assets for 2024 was -88%, a 40% increase from 2023.
  • Unicycive Therapeutics, Inc. annual Return On Assets for 2023 was -146%, a 16% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Unicycive Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -95% -34% -55% 01 Jul 2025 30 Sep 2025
Q2 2025 -98% -27% -38% 01 Apr 2025 30 Jun 2025
Q1 2025 -43% +93% +69% 01 Jan 2025 31 Mar 2025
Q4 2024 -88% +58% +40% 01 Oct 2024 31 Dec 2024
Q3 2024 -61% +94% +60% 01 Jul 2024 30 Sep 2024
Q2 2024 -71% +115% +62% 01 Apr 2024 30 Jun 2024
Q1 2024 -136% +84% +38% 01 Jan 2024 31 Mar 2024
Q4 2023 -146% +28% +16% 01 Oct 2023 31 Dec 2023
Q3 2023 -155% -48% -44% 01 Jul 2023 30 Sep 2023
Q2 2023 -186% -96% -106% 01 Apr 2023 30 Jun 2023
Q1 2023 -220% -128% -141% 01 Jan 2023 31 Mar 2023
Q4 2022 -174% 01 Oct 2022 31 Dec 2022
Q3 2022 -108% 01 Jul 2022 30 Sep 2022
Q2 2022 -90% 01 Apr 2022 30 Jun 2022
Q1 2022 -91% 01 Jan 2022 31 Mar 2022

Unicycive Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -88% +58% +40% 01 Jan 2024 31 Dec 2024
2023 -146% +28% +16% 01 Jan 2023 31 Dec 2023
2022 -174% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.